Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Enterome
Enterome
Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect
Fierce Biotech
Mon, 07/18/22 - 10:00 am
Nestle
Enterome
food allergies
IBD
Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work
Endpoints
Thu, 06/25/20 - 10:32 am
Takeda
Enterome
microbiome
R&D
France's Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate
BioSpace
Thu, 11/7/19 - 10:54 pm
Enterome
Memorial Sloan Kettering
microbiome
cancer immunotherapy
Microbiome Report for Week Ending 4/6/19
CP Wire
Fri, 04/12/19 - 09:59 am
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Microbiome Report for Week Ending 4/6/19
Fri, 04/12/19 - 09:52 am
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Microbiome Report for week ending 3/30/19
CP Wire
Sat, 04/6/19 - 02:30 pm
microbiome
Enterome
LNC Therapeutics
Microbiome Report for week ending 3/30/19
Sat, 04/6/19 - 02:28 pm
microbiome
Enterome
LNC Therapeutics
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
CP Wire
Thu, 03/28/19 - 12:04 pm
Enterome
immuno-oncology
glioblastoma multiforme
molecular mimicry
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
Thu, 03/28/19 - 11:55 am
Enterome
immuno-oncology
glioblastoma multiforme
Microbiome Report for week ending 3/23/19
CP Wire
Tue, 03/26/19 - 09:41 am
microbiome
Enterome
Rebiotix
Symbiotix Biotherapies
Microbiome Report for week ending 3/23/19
Tue, 03/26/19 - 09:36 am
microbiome
Enterome
Rebiotix
Symbiotix Biotherapies
Enterome to Collaborate with Dana-Farber Cancer Institute on Microbiome Immunotherapies
CP WIre
Thu, 03/21/19 - 06:45 pm
Enterome
cancer
cancer immunotherapies
Enterome to Collaborate with Dana-Farber Cancer Institute on Microbiome Immunotherapies
Thu, 03/21/19 - 01:08 pm
Enterome
Microbiome Report for Week Ending 10/27/18
CP Wire
Wed, 10/31/18 - 06:41 pm
Enterome
Takeda Pharmaceuticals
Microbiotica
microbiome
Microbiome Report for Week Ending 10/27/18
Wed, 10/31/18 - 12:39 pm
Enterome
Takeda Pharmaceuticals
Microbiotica
microbiome
Microbiome Biotech Enterome and Takeda sign Crohn's Deal Worth Up To $600 Million+
CP Wire
Thu, 10/25/18 - 11:27 pm
Enterome
Takeda
Crohn's Disease
EB8018
Microbiome Biotech Enterome and Takeda sign Crohn's Deal Worth Up To $600 Million+
Thu, 10/25/18 - 12:41 pm
Enterome
Takeda
Crohn's Disease
EB8018
5 biotech CEOs on payers, investors and big bets
BioPharma Dive
Fri, 03/10/17 - 09:42 am
biotech
payers
investors
Gil Van Bokkelen
Athersys
Robert McNeil
DalCor Pharmaceuticals
Pierre Belichard
Enterome
Michael Metzger
Syndax
Spiro Rombotis
Cyclacel